An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients

被引：0
|
作者：
Park, K
Koh, YB
Kwak, JY
Kim, SJ
Yoon, YS
Kang, CM
Kim, YS
机构：
[1] YONSEI UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
[2] CATHOLIC UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
[3] CATHOLIC UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA
[4] HANYANG UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
[5] HANYANG UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA
[6] SEOUL NATL UNIV,COLL MED,DEPT SURG,SEOUL,SOUTH KOREA
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1202 / 1203
页数：2
相关论文
共 50 条
  • [31] A randomized, multicenter, double-blind study of Neoral vs Sandimmune in patients undergoing liver transplantation
    Roy, A
    Grant, DR
    Kneteman, NM
    Tchervenkov, JI
    Levy, GA
    Tan, A
    Hendricks, L
    ANNALES DE CHIRURGIE, 1998, 52 (08): : 716 - 721
  • [32] Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral
    Marsh, CL
    THERAPEUTIC DRUG MONITORING, 1999, 21 (01) : 27 - 34
  • [33] Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: Results from an international randomized controlled trial
    Peeters, P
    Kazek, M
    Abella, I
    Noble, I
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1838 - 1842
  • [34] Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method
    First, MR
    Weiskittel, P
    Shah, M
    Peddi, VR
    Canafax, D
    Schroeder, TJ
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 3955 - 3957
  • [35] Safe and cost effective conversion from neoral to consupren soft gelatin capsules in stable renal transplant patients: A 1-year study
    Masri, MA
    Barbari, A
    Stephan, A
    Kamel, G
    Aoun, S
    Rizk, S
    Karam, A
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (08) : 3302 - 3303
  • [36] Superior renal allograft survival with cyclosporine-based immunosuppression: Results of a double-blind, randomized, prospective comparison of neoral and sandimmune in cadaveric renal transplant recipients.
    Hricik, DE
    TRANSPLANTATION, 1999, 67 (07) : S150 - S150
  • [37] Conversion of stable renal transplant patients from sandimmune to cyclosporine (CsA) microemulsion: An 18-months follow-up.
    Shihab, FS
    Corbett, JL
    Kaul, R
    Hansen, AP
    Nelson, EW
    Holman, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3272 - A3272
  • [38] A Pharmacokinetic Study of Cyclosporin (Sandimmune®)Factors Affecting the Usefulness of Trough Levels in Predicting Drug Exposure in Renal Transplant Patients
    Dennis R. N. Primmett
    Marc Levine
    Rebecca Wrishko
    Paul A. Keown
    Clinical Drug Investigation, 1997, 13 : 23 - 36
  • [39] A randomized, controlled, double-blind study of the safety and tolerability of sandimmun neoral in stable renal transplant patients
    Massari, PU
    Grosso, S
    deBoccardo, G
    Vasquez, MC
    Schiavelli, RO
    Sabbatiello, RR
    Casadei, DH
    Rial, MD
    Jost, LJ
    Turin, MD
    Carreno, CAA
    Maggiora, EC
    Gadea, MM
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3365 - 3367
  • [40] A pharmacokinetic study of cyclosporin (Sandimmune(R)) - Factors affecting the usefulness of trough levels in predicting drug exposure in renal transplant patients
    Primmett, DRN
    Levine, M
    Wrishko, R
    Keown, PA
    CLINICAL DRUG INVESTIGATION, 1997, 13 (01) : 23 - 36
12345